1. Home
  2. TRML vs CGBD Comparison

TRML vs CGBD Comparison

Compare TRML & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • CGBD
  • Stock Information
  • Founded
  • TRML 2021
  • CGBD 2012
  • Country
  • TRML United States
  • CGBD United States
  • Employees
  • TRML N/A
  • CGBD N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • CGBD Finance: Consumer Services
  • Sector
  • TRML Health Care
  • CGBD Finance
  • Exchange
  • TRML Nasdaq
  • CGBD Nasdaq
  • Market Cap
  • TRML 1.2B
  • CGBD 1.0B
  • IPO Year
  • TRML N/A
  • CGBD 2017
  • Fundamental
  • Price
  • TRML $47.90
  • CGBD $12.13
  • Analyst Decision
  • TRML Hold
  • CGBD Hold
  • Analyst Count
  • TRML 12
  • CGBD 5
  • Target Price
  • TRML $47.04
  • CGBD $14.25
  • AVG Volume (30 Days)
  • TRML 957.5K
  • CGBD 620.6K
  • Earning Date
  • TRML 11-06-2025
  • CGBD 11-04-2025
  • Dividend Yield
  • TRML N/A
  • CGBD 13.19%
  • EPS Growth
  • TRML N/A
  • CGBD N/A
  • EPS
  • TRML N/A
  • CGBD 1.14
  • Revenue
  • TRML N/A
  • CGBD $234,464,000.00
  • Revenue This Year
  • TRML N/A
  • CGBD $15.09
  • Revenue Next Year
  • TRML N/A
  • CGBD $6.01
  • P/E Ratio
  • TRML N/A
  • CGBD $10.60
  • Revenue Growth
  • TRML N/A
  • CGBD N/A
  • 52 Week Low
  • TRML $11.56
  • CGBD $12.07
  • 52 Week High
  • TRML $48.27
  • CGBD $18.64
  • Technical
  • Relative Strength Index (RSI)
  • TRML 91.37
  • CGBD 25.77
  • Support Level
  • TRML $47.83
  • CGBD $12.28
  • Resistance Level
  • TRML $47.94
  • CGBD $12.74
  • Average True Range (ATR)
  • TRML 0.11
  • CGBD 0.30
  • MACD
  • TRML -0.63
  • CGBD -0.09
  • Stochastic Oscillator
  • TRML 38.14
  • CGBD 2.87

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: